Merck (MRK) Gross Profit (2009 - 2026)
Merck (MRK) reported Gross Profit of $12.1 billion for Q1 2026, little changed year-over-year from $12.1 billion in Q1 2025, and up 11.45% quarter-over-quarter from $10.8 billion in Q4 2025.
Merck (MRK) Gross Profit (2009 - 2026) Analysis & Trends
Merck (MRK) has 18 years of Gross Profit data on file, last reported at $12.1 billion in Q1 2026.
- Gross Profit for Q1 2026 came in at $12.1 billion, changed 0.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $48.6 billion (changed 0.49% YoY), and the FY2025 annual result was $48.6 billion, down 0.71% from the prior year.
- Gross Profit grew to $12.1 billion in Q1 2026 per MRK's latest filing, from $10.8 billion in the prior quarter.
- Over five years, Gross Profit peaked at $13.4 billion in Q3 2025 and troughed at $9.9 billion in Q4 2022.
- A 5-year average of $11.5 billion and a median of $11.7 billion in 2023 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2022 and 2025: Gross Profit soared 41.64% in 2022, then retreated 8.03% in 2025.
- A 5-year view of Gross Profit shows it stood at $9.9 billion in 2022, then advanced by 7.73% to $10.7 billion in 2023, then gained by 10.06% to $11.8 billion in 2024, then dropped by 8.03% to $10.8 billion in 2025, then climbed by 11.45% to $12.1 billion in 2026.
- Business Quant data shows MRK's Gross Profit at $12.1 billion in Q1 2026, $10.8 billion in Q4 2025, and $13.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.09 Bn |
| Mar 31, 2026 | 12.09 Bn |
| Dec 31, 2025 | 10.85 Bn |
| Dec 31, 2025 | 10.85 Bn |
| Sep 30, 2025 | 13.42 Bn |
| Sep 30, 2025 | 13.42 Bn |
| Jun 30, 2025 | 12.25 Bn |
| Jun 30, 2025 | 12.25 Bn |
| Mar 31, 2025 | 12.11 Bn |
| Mar 31, 2025 | 12.11 Bn |
| Dec 31, 2024 | 11.80 Bn |
| Dec 31, 2024 | 11.80 Bn |
| Sep 30, 2024 | 12.58 Bn |
| Sep 30, 2024 | 12.58 Bn |
| Jun 30, 2024 | 12.37 Bn |
| Jun 30, 2024 | 12.37 Bn |
| Mar 31, 2024 | 12.24 Bn |
| Mar 31, 2024 | 12.24 Bn |
| Dec 31, 2023 | 10.72 Bn |
| Dec 31, 2023 | 10.72 Bn |